Body mass index (BMI) may not provide the most accurate screening for skeletal muscle deficits among youth with pediatric‐onset inflammatory bowel disease (IBD), according to a study in the Journal of ...

Treatment with RBL was effective against recurrent CDI among high-risk patients when administered at home or in clinical settings.

The FDA approved Mavyret for the treatment of patients 3 years and older with acute or chronic HCV infection without cirrhosis or with compensated cirrhosis.

The US FDA says it plans to use artificial intelligence to help speed the approval of new drugs and medical devices.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

Janus kinase (JAK) inhibitors are not associated with an increased risk for gastrointestinal perforation (GIP) among patients with rheumatoid arthritis (RA), according to study results published in ...

While CVS hospitalizations have declined, the illness continues to present among young women, Black individuals, and leads to high costs among Hispanic patients.

Adding perioperative systemic therapy to CRS-HIPEC can improve some outcomes in patients with resectable colorectal peritoneal metastases, data suggest.

Federal health officials pulled back a key recommendation that pregnant women get the COVID-19 vaccine, causing sharp criticism from experts.

Compared with BMI, waist-to-height ratio offered stronger predictive value for liver fibrosis and steatosis outcomes. Waist-to-height ratio (WHtR) cutoffs better predict liver steatosis and fibrosis ...

Ambulatory acute kidney injury is common among individuals with cirrhosis and is associated with a high 90-day mortality.